Home Cart Sign in  
Chemical Structure| 42399-41-7 Chemical Structure| 42399-41-7

Structure of Diltiazem
CAS No.: 42399-41-7

Chemical Structure| 42399-41-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Diltiazem is an orally active L-type Ca²⁺ channel blocker with antihypertensive and antiarrhythmic properties, suitable for arrhythmia, hypertension, and angina research.

Synonyms: Diltiazem

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Diltiazem

CAS No. :42399-41-7
Formula : C22H26N2O4S
M.W : 414.52
SMILES Code : O=C1[C@@H]([C@@H](SC2=C(N1CCN(C)C)C=CC=C2)C3=CC=C(OC)C=C3)OC(C)=O
Synonyms :
Diltiazem
MDL No. :MFCD00868239
InChI Key :HSUGRBWQSSZJOP-RTWAWAEBSA-N
Pubchem ID :39186

Safety of Diltiazem

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H302
Precautionary Statements:P501-P270-P264-P280-P337+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00893100 Pain PHASE4 COMPLETED 2025-12-08 Sina General Hospital, Tehran,... More >> Iran, Islamic Republic of Less <<
NCT04222855 Postpartum Preeclampsia COMPLETED 2009-05-30 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.41mL

0.48mL

0.24mL

12.06mL

2.41mL

1.21mL

24.12mL

4.82mL

2.41mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories